Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-07-23

Clinical Trial Update: Chinese Herbal Medicine for Gynecologic Patients [Phase 2]

View source ↗

Summary

This Phase 2 trial investigating Chinese Herbal Medicine for dysmenorrhea in gynecologic patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chinese Herbal Medicine (herbal formulation)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Dysmenorrhea | Phase 2 | Status: WITHDRAWN